| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
510,820,000 |
| Market
Cap: |
20.91(B) |
| Last
Volume: |
2,161,941 |
Avg
Vol: |
3,675,652 |
| 52
Week Range: |
$31.71 - $49.29 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 716 |
| Guru Rank Value : 1.5 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and patients at home under physician supervision. Co. manages its business based on the following geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
64,488 |
64,488 |
64,488 |
131,708 |
| Total Sell Value |
$2,618,858 |
$2,618,858 |
$2,618,858 |
$5,579,361 |
| Total People Sold |
1 |
1 |
1 |
3 |
| Total Sell Transactions |
1 |
1 |
1 |
4 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sonig Alok |
EVP, Group President, PharmOff |
• – – |
2023-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,798 |
|
- |
|
| Rasul Reaz |
EVP, Group Pres, HealthcareOff |
• – – |
2023-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,054 |
|
- |
|
| Franzi Cristiano |
SVP, President, EMEA |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,113 |
102,292 |
|
- |
|
| Rasul Reaz |
EVP, Group Pres, Healthcare |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,428 |
27,482 |
|
- |
|
| Mason Jeanne K |
SVP, Human Resources |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,491 |
139,282 |
|
- |
|
| Knight Heather |
EVP, Group Pres, Medical |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
54,611 |
|
- |
|
| Rosenbloom David S. |
SVP and General Counsel |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,885 |
56,101 |
|
- |
|
| Almeida Jose E |
Chairman, CEO and President |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
67,884 |
413,096 |
|
- |
|
| Kunzler Jacqueline |
SVP, Chief Quality Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,171 |
22,896 |
|
- |
|
| Flynn Steven |
SVP, President, APAC |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,514 |
31,080 |
|
- |
|
| Sonig Alok |
EVP, Group President, Pharm |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,428 |
33,226 |
|
- |
|
| Saccaro James |
EVP, Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,217 |
178,961 |
|
- |
|
| Borzi James W |
SVP, Global Supply Chain |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,640 |
20,552 |
|
- |
|
| Stevens Brian |
SVP, CAO and Controller |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,788 |
33,660 |
|
- |
|
| Kunzler Jacqueline |
SVP, Chief Quality Officer |
• – – |
2023-02-21 |
4 |
S |
$40.50 |
$154,427 |
D/D |
(3,813) |
16,725 |
|
- |
|
| Kunzler Jacqueline |
SVP, Chief Quality Officer |
• – – |
2023-02-21 |
4 |
OE |
$37.82 |
$157,445 |
D/D |
4,163 |
20,538 |
|
- |
|
| Stevens Brian |
SVP, CAO and Controller |
• – – |
2023-02-13 |
4 |
D |
$40.50 |
$9,072 |
D/D |
(224) |
26,872 |
|
- |
|
| Stevens Brian |
SVP, CAO and Controller |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
646 |
27,096 |
|
- |
|
| Almeida Jose E |
Chairman, CEO and President |
• – – |
2023-02-13 |
4 |
D |
$40.50 |
$407,147 |
D/D |
(10,053) |
345,212 |
|
- |
|
| Almeida Jose E |
Chairman, CEO and President |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
31,044 |
355,265 |
|
- |
|
| Kunzler Jacqueline |
SVP, Chief Quality Officer |
• – – |
2023-02-13 |
4 |
D |
$40.50 |
$28,958 |
D/D |
(715) |
16,375 |
|
- |
|
| Kunzler Jacqueline |
SVP, Chief Quality Officer |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,068 |
17,090 |
|
- |
|
| Flynn Steven |
SVP, President, APAC |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
516 |
12,502 |
|
- |
|
| Saccaro James |
EVP, Chief Financial Officer |
• – – |
2023-02-13 |
4 |
D |
$40.50 |
$42,890 |
D/D |
(1,059) |
156,744 |
|
- |
|
| Saccaro James |
EVP, Chief Financial Officer |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,362 |
157,803 |
|
- |
|
1255 Records found
|
|
Page 4 of 51 |
|
|
0.09 (0.22%) 
